3-oxo-4-phenylbutanamide | 95395-81-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-oxo-4-phenylbutanamide
• CAS: 95395-81-6
• 化学式: C₁₀H₁₁NO₂
• 分子量: 177.203
• InChiKey: UDSDVAYDAHFQRV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  60.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-oxo-4-phenylbutanamide 在 platinum(IV) oxide 氢气 、 溶剂黄146 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 40.0 ℃ 、620.53 kPa 条件下， 反应 108.0h， 生成 (3R)-3-{[(1S)-2-amino-2-oxo-1-phenylethyl]amino}-4-phenylbutanamide
  参考文献：
  名称：

  Highly Diastereoselective Heterogeneously Catalyzed Hydrogenation of Enamines for the Synthesis of Chiral β-Amino Acid Derivatives

  摘要：

  Pure (Z)-enamines readily prepared from beta-ketoesters and amides using (S)-phenylglycine amide were hydrogenated with very high diastereoselectivities (up to 200:1) using heterogeneous catalysis. Hydrogenolytic cleavage of the (S)-phenylglycine amide afforded the corresponding chiral beta-aminoesters and amides. The high geometrical purity of the (Z)-enamine and a simple activation procedure for the PtO2 catalyst are essential in achieving high selectivity.

  DOI：

  10.1021/ja038812t
• 作为产物：
  描述：

  6-benzyl-2,2-dimethyl-2H,4H-1,3-dioxin-4-one 在 氨 作用下， 以 xylene 为溶剂， 生成 3-oxo-4-phenylbutanamide
  参考文献：
  名称：

  Sato, Masayuki; Ogasawara, Hiromichi; Komatsu, Sachiko, Chemical and pharmaceutical bulletin, 1984, vol. 32, # 10, p. 3848 - 3856

  摘要：

  DOI：

文献信息

• [EN] CYCLIC DIARYLBORON DERIVATIVES AS NLRP3 INFLAMMASOME INHIBITORS<br/>[FR] DÉRIVÉS DE DIARYLBORON CYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS D'INFLAMMASOME NLRP3
  申请人：UNIV MANCHESTER

  公开号：WO2017017469A1

  公开（公告）日：2017-02-02

  Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 β activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.

  抑制剂化合物已被披露。这些化合物在治疗与白细胞介素1β活性有关的疾病或症状中具有有效性。此外，还披露了合成这些化合物的方法，以及包含这些化合物的药物组合物。
• [EN] PROCESS TO CHIRAL BETA-AMINO ACID DERIVATIVES<br/>[FR] PROCEDE DE SYNTHESE DE DERIVES D'ACIDES AMINES BETA CHIRAUX
  申请人：MERCK & CO INC

  公开号：WO2004085661A2

  公开（公告）日：2004-10-07

  The present invention relates to a process for the synthesis of chiral beta-amino acid derivatives and in particular to a process for the preparation of enantiomerically enriched beta-amino acid amide inhibitors of dipeptidyl peptidase-IV (DP-IV) which are useful for the treatment of Type 2 diabetes.

  本发明涉及一种手性β-氨基酸衍生物的合成过程，特别是一种制备对二肽基肽酶-IV（DP-IV）具有对映选择性的β-氨基酸酰胺抑制剂的方法，该抑制剂对2型糖尿病的治疗有用。
• N,N-disubstituted alkenamides and phenylalkenamides, processes for their production and their use as pharmaceuticals
  申请人：SANDOZ AG

  公开号：EP0084292A1

  公开（公告）日：1983-07-27

  Alkenamides and phenylalkenamides having the formula I wherein n represents 0 or 1 R represents C1-4alkyl or the group wherein R2 and R3 represent independently C1-4alkyl or together with the nitrogen atom to which they are attached pyrrolidino, piperidino, hexamethyleneimino or morpholino R, and R4 represent independently halogen C1-4alkyl or C1-4-alkoxy and R5 represents hydrogen or C1-6alkyl, and acid addition salts thereof. The compounds are useful as pharmaceuticals particularly as agents for treating diabetes.

  具有式 I 的烯酰胺和苯基烯酰胺 其中 n 代表 0 或 1 R 代表 C1-4 烷基或 R2 和 R3 独立地代表 C1-4 烷基或连同其所连接的氮原子代表吡咯烷基、哌啶基、六亚甲基亚氨基或吗啉基的基团，R2 和 R4 独立地代表卤素 C1-4 烷基或 C1-4 烷氧基，R5 代表氢或 C1-6 烷基，以及它们的酸加成盐。 这些化合物可用作药物，特别是治疗糖尿病的药物。
• Intermediate for composite materials
  申请人：MITSUBISHI RAYON CO., LTD.

  公开号：EP0173137A2

  公开（公告）日：1986-03-05

  An intermediate for a composite material is disclosed. The intermediate is obtained by impregnating an epoxy resin composition containing a specific additive into a reinforcing material. The composite material obtained from the intermediate has improved mechanical properties.

  本发明公开了一种用于复合材料的中间体。 这种中间体是通过将含有特定添加剂的环氧树脂组合物浸渍到增强材料中而获得的。 由这种中间体获得的复合材料具有更好的机械性能。
• Process for the preparation of concentrated 1:2 metal complex dye preparations
  申请人：CIBA-GEIGY AG

  公开号：EP0430880A2

  公开（公告）日：1991-06-05

  Stable, concentrated, liquid preparations of 1: 2 metal complex azo or azomethine dyes are obtained by metallizing the metal-free azo or azomethine intermediates containing at most one sulfonic acid group in form of their moist, almost salt-free washed, filter cakes with aqueous slurries of complex forming, preferably cobalt or chromium salts. Without isolation of the thus obtained metal complex dyes the dye slurries are then in situ converted into the stable, concentrated dye preparations by adjusting them to a final dye concentration. The dye preparations are produced in a very economic manner by avoiding any isolation of the metal complex dyes after the metallization step and by considerably reducing the amounts of effluents. The dye preparations obtained are suitable for the preparation of dye-baths or printing pastes which may be used in particular for dyeing and printing textile materials made of natural or synthetic polyamide fibres, and further of leather and paper.

  将含有最多一个磺酸基团的无金属偶氮或偶氮亚甲基中间体与形成络合物（最好是钴盐或铬盐）的水性浆液一起，以湿润的、几乎无盐的水洗滤饼的形式进行金属化，可获得稳定的、浓缩的、液态的 1:2 金属络合偶氮或偶氮亚甲基染料制剂。在不分离由此获得的金属络合染料的情况下，通过调节最终染料浓度，将染料浆就地转化为稳定的浓缩染料制剂。 由于避免了金属化步骤后金属络合染料的分离，并大大减少了废水量，因此染料制剂的生产非常经济。 获得的染料制剂适用于制备染料浴或印花浆，尤其可用于天然或合成聚酰胺纤维纺织品的染色和印花，以及皮革和纸张的染色和印花。